GALMED PHARMACEUTICALS LTD. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
GALMED PHARMACEUTICALS LTD. (GLMD) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $199.00 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2024-04-04
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|
| 2021-12-31 | $199.00K 20-F · filed 2024-04-04 | |
| 2020-12-31 | $35.00K 20-F · filed 2023-03-29 | |
| 2020-06-30 | $35.00K 6-K · filed 2020-08-06 | |
| 2019-12-31 | $653.00K 20-F · filed 2021-03-18 | |
| 2019-06-30 | $679.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | $0.00 20-F · filed 2021-03-18 | |
| 2018-06-30 | $0.00 6-K · filed 2019-08-05 | |
| 2017-12-31 | $0.00 20-F · filed 2020-03-12 |